FOLH1 and prostate carcinoma: The increasing availability of imaging modalities as choline PET-CT and especially prostate-specific membrane antigen (PSMA) PET-CT empower the earlier detection of a single or a limited number of metastases [86] and consequently increase the incidence of oligometastatic prostate cancer.